NEURONES: Description of the share buyback program - Effective implementation

INFORMATION

Nanterre, March 16, 2020 (after the closing of the stock exchange)

DESCRIPTION OF THE SHARE BUYBACK PROGRAM

EFFECTIVE IMPLEMENTATION

The Combined Shareholders’ Meeting held on June 6, 2019 renewed the authorization granted to the Board of Directors, for a period of 18 months, to purchase or cause to be purchased the company's own shares.

Pursuant to Articles 241-1 et seq. of the General Regulation of the Autorité des Marchés Financiers, and pursuant to Commission Delegated Regulation (EU) 2016/1052 supplementing Regulation (EU) No. 596/2014 with regard to regulatory technical standards for the conditions applicable to buyback programs and AMF-approved market practices, this description sets out the objectives and the terms and conditions of the buyback program under which NEURONES (henceforth "the Company") will buy back its own shares, along with the conditions for its effective implementation laid down by the Board of Directors.

1.

Breakdown by objective of the securities held

On February 28, 2020, the number of shares held directly or indirectly by the Company stood at 9,422, representing less than 0.04% of the total capital of 24,285,862 shares.

These shares are held for the purposes of supporting the market for the Company's shares under the liquidity agreement concluded with CIC on August 1, 2019.

Description of the share buyback program authorized by the Shareholders’ Meeting Authorization of the program: sixteenth resolution of the Combined Shareholders' Meeting of June 6, 2019 Shares concerned: NEURONES common shares (ISIN Code: FR0004050250) Maximum share of the capital approved by the Shareholders' Meeting for buyback: 10% of the Company's capital (i.e. 2,428,586 shares to date). However, by law, the number of shares acquired with a view to subsequently offering them for exchange or payment during external growth operations may not exceed 5% of the share capital. Maximum purchase price: 30 euros (excluding acquisition costs) per share. However, it should be noted that the maximum purchase price will be adjusted, if need be, should the company undertake financial operations or make decisions affecting the share capital. Maximum value of the program authorized by the Shareholders' Meeting: 72,857,580 euros Program objectives authorized by the Shareholders' Meeting:

The Shareholders' Meeting, ruling pursuant to the provisions of Article L.225-209 of the French Commercial Code, after having reviewed the management report, authorizes the Board of Directors, for a period not exceeding 18 months from this Meeting, to purchase the Company's own shares in order to:

1) subsequently cancel them;

2) cover:a. stock option plans and other forms of share allocation to employees and/or to Group officers, in particular for Company profit sharing, a Company Savings Plan (CSP) or the allocation of free shares;b. financial securities conferring the right to receive Company shares;

3) support the share price through an Investment Service Provider via a liquidity agreement pursuant to the code of professional conduct of the Association Fran?aise des Marchés Financiers (French Association of Financial Markets);

4) hold purchased shares for subsequent use as exchange or payment during an acquisition.

The shares may be purchased by intervening on the market or by purchasing blocks, without any specific limitation on such block acquisitions.

Duration of the authorization to implement the program:

18 months from the Shareholders’ Meeting, i.e. up to December 6, 2020.

Effective implementation of the share buyback program authorized by the Shareholders' Meeting

The Company's Board of Directors has decided to implement the share buyback program authorized by the Shareholders' Meeting in order to pursue the following two objectives:

-

Support the market for the Company's shares, in particular to encourage their liquidity, via a liquidity agreement pursuant to a code of professional conduct recognized by the AMF, and concluded with an investment service provider in compliance with AMF-approved market practice.

The Company points out that it allocated the cash sum of 400,000 euros to implementing the liquidity agreement concluded on August 1, 2019 with CIC.

-

Cancel the shares bought back in order to reduce the company's share capital, within the framework of and subject to a current authorization from the Shareholders' Meeting

The Board points out that the maximum number of shares that can be acquired for this purpose has been set at 2,000,000, at a maximum price of 21 euros per share (excluding acquisition costs), which represents a maximum total of 42 million euros (excluding costs). This implementation will be effective once this description has been circulated.

About NEURONES

With 5,400 experts, the NEURONES Group specializes in Consulting (Management, Organization and Digital) and IT Services. It supports its clients in their digital transformation projects and in the upgrading of their Information Systems.

Euronext Paris (compartment B - NRO) - Enternext Tech 40 – SRD medium values

http://www.neurones.net

Investor Relations:

NEURONES

Paul-César Bonnel

Tel.: +33 (0)1 41 37 41 37

investisseurs@neurones.net

Attachment

NEURONES-Share-buyback-program-Effective-implementation-march-2020

信息

Nanterre，2020年3月16日(股票交易所关闭�p>

股份回购计划说�>

有效执行

2019年6月6日举行的合并股东�映ち硕远禄峁郝才殴郝竟煞莸氖谌ǎ�18��

根据第241-1�浜凇�3月és�易芴敝校�(欧盟)第596/2014号补充�欧盟)关于回购方案和AMF批准的市场�视锰募喙芗际嫉�(欧盟)第2016/1052号委员会授权�舅得毓杭苹哪勘旰吞吞菡庑┠勘旰吞�(此�肮尽�)将回购自己的股票，以及董事会规定的有效执行该方案的��

1.按所持证券的目标分列的细目

2020年2月28日，该公司直接�映钟械墓煞菸�9 422股，占总股本24 285 862股的0.04%。

根据2019年8月1日与中投达成的�孕椋钟姓庑┕善笔俏酥С指霉竟善钡氖谐　�

股东�谌ǖ墓煞莼毓杭苹得019年6月6日合并股东会第十六次�荷胀ü�(ISIN代码：FR0004050250)股东�蓟毓旱淖时镜淖罡叻荻睿汗咀时镜�10%(即迄�沟�2，428，586股)。但是，根据法律，在外部�滴洌┙换换抖郝煞菔坎坏贸杀镜�5%。最高收购价：每股30欧元(不包括收购成本)。不过，须注意的是，如有需要，如公司进行财�跋旃杀镜木罡吖郝９啥嫉募苹淖罡呒壑担汗啥嫉南钅磕勘�72，857，580欧元：

股东会根据“法国商法典”第L.225-209�娑ǎ谏斯芾肀ǜ婧谌ǘ禄岽颖敬位嵋槠�18�氖奔涔郝咀约旱墓煞荩员悖�

(1)随��

(2)包括：A.股票期权计划和其他形式的股份分配给雇员和/�殴僭保乇纠怼⒐敬⑿罴苹压煞莸姆峙洌籅.授予接受公司股份权利的�と�

3)根据法国�谐⌒�(法国�谐⌒�)的专业行为守�ü蹲史┥掏ü孕橹С止杉郏�

(四)在收购过程中，持有被收购的股票，用于交换�Ц丁�

这些股票可以通过在市场上进行干预�郝槔垂郝源死啻展好挥腥魏尉咛逑拗啤Ｖ葱懈梅桨傅氖谌ㄆ谙蓿捍庸啥粗�2020年12月6日。

股东�谌ɑ毓杭苹挠行凳�

公司董事会�凳┕啥谌ǖ墓善被毓杭苹允迪忠韵铝礁辏�

-支持该公司股票的市场，特�睦淞裕軦MF认可的专业行为守�闪孕椋凑誂MF批准的市场惯例与投资服�┥痰藿嵝椤�

该公司指�峙淞�40�南纸糜谥葱�2019年8月1日与中投达成的�孕椤�

-在股东�目冢⒃诠啥壳笆谌ǖ那榭∠竟杀径毓旱墓煞�

�被嶂赋四康目苫墓煞莸淖罡呤慷ㄎ�2 000 000股，最高价�抗�21欧元(不包括购置费用)，最高总额为4 200��(不包括费用)。这一实施将在这一说�⒑А�

关于��

该集团拥有5，400名专家，专门从事咨询(管理、组织和数字)和信息技�С挚突У氖指脑煜钅亢托畔⑾低车纳丁�

泛欧巴黎(B-NRO室)-EnterNext Tech 40-SRD中档

http://www.neurones.net

投资者关系：

��

保罗·塞萨尔·邦内尔

电话：+33(0)1 41 37 41 37

邀请者@Neurones.net

附件NEURONES-Share-buyback-program-Effective-implementation-march-2020

免�形姆胗商谘斗刖峁┲С郑煌径苑胄畔⒌淖既沸曰啃运斐傻娜魏嗡怀械Ｈ魏卧�